A Brand of Science and Medicine Group

Empowering Global Innovation with a Community of Scientific Experts

Since 1994, BioInformatics has been the leading research and advisory partner to the life science and diagnostics industries. We believe that the most groundbreaking scientific advancements are fueled by deep, authentic understanding. Our purpose is to bridge the gap between the world’s leading life science suppliers and the scientists who are shaping the future of discovery. By leveraging the insights of the Science Advisory Board — our proprietary network of over 50,000 experts — we transform raw data into the strategic clarity needed to drive product innovation and market growth. We are dedicated to providing the intelligence that empowers our partners to support the scientific community and advance the boundaries of human knowledge.

Learn More About Us
Two scientists reviewing a survey online

Industries We Serve

Analytical Instrumentation  •   Drug Discovery   •   Life Science Research   

Contact Us to Get Started

Our Solutions

Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.

Lead Generation

Connect with industry professionals through tailored lead generation solutions for manufacturers in various sectors.

Learn More

Thought Leadership

Elevate your brand's thought leadership status within niche communities for sustained success.

Learn More

Value Proposition

Create compelling value propositions by understanding customer needs, preferences, and pain points through market research.

Learn More

Website Traffic

Direct targeted traffic to your site, ensuring optimal visibility and engagement across industries.

Learn More

Latest Resource

More Resources
BioInformatics logo

NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026

March 11, 2026

Aaron Brown

Since the FDA and NIH signaled their pivot toward New Approach Methodologies (NAMs) early last year, the most meaningful developments have been in how quickly those signals have turned into practical pathways. FDA’s 2025 roadmap began allowing NAM‑supported INDs—initially for monoclonal antibodies—with options for streamlined review where data are strong. NIH reinforced the shift by…

Latest Market Reports

 

Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.

More Reports

Our Customers

Our Brands

Life Sciences

BioInformatics logo

Deep commercial insights, in-depth analyses into pivotal markets, cutting-edge technologies, and invaluable customer insights developed by primary research, equipping you with data-driven strategies to market to scientists effectively.

View New Research Reports

Laboratory Diagnostics

Kalorama Information logo

Market analysis, sizing, and segmentation developed by end-market specialists and bolstered by secondary sources.

View New Research Reports

Instrument Business Outlook

Instrument Business Outlook logo

The latest curated industry news, information, and trends to deliver the most analytical instrument insight with the least time investment for executives and investors.

View Newsletter

Imaging Diagnostics

IMV logo

Modality-specific reports identifying market trends, purchasing habits, future plans, procedure volumes, and lab budgets.

View New Research Reports

Analytical Instruments

SDi logo

Technology reports with a detailed and concise global perspective of specific markets, market size, growth, and vendor share.

View New Research Reports